Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their signed informed consent to participate
- People with suspected or confirmed non-small cell lung cancer (a common type of lung cancer) located in the upper part of either lung
- People who have a lung nodule (a small growth in the lung) that is suspected to be non-small cell lung cancer
- People whose lung mass measures 7 cm or smaller at its widest point, as measured by a CT scan of the chest and upper abdomen
- People whose cancer is at an early stage, classified as clinical stage I or stage II (meaning it has not spread far)
- People who are not currently pregnant or breastfeeding
- Women who have not yet gone through menopause and have had a negative pregnancy test
- People who are able to have children and are using effective contraception
- People who had a previous cancer more than 5 years ago, as long as that cancer was not a type of skin cancer (non-melanoma) or a very early-stage cancer that had not spread (in-situ cancer)
Who may not be able to join:
- No specific exclusion criteria were listed in the official trial documentation (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Local Control Rate at 1 year
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.